Net Cash Provided by (Used in) Operating Activities |
-2.26M |
USD |
-10.7% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-21K |
USD |
-10.5% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-96K |
USD |
-37.1% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
20M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
6.88M |
shares |
+0.83% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-2.38M |
USD |
-11.6% |
Q1 2025 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
3K |
USD |
-50% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
4.1M |
USD |
+12.4% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
4.56M |
USD |
+11.9% |
Q4 2024 |
FY 2024 |
Payments to Acquire Property, Plant, and Equipment |
45K |
USD |
-35.7% |
Q1 2025 |
Q1 2025 |
Property, Plant and Equipment, Gross |
22.3M |
USD |
-1.8% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
679K |
USD |
-20% |
Q4 2024 |
FY 2024 |
Current Income Tax Expense (Benefit) |
16K |
USD |
|
Q1 2025 |
Q1 2025 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
466K |
USD |
+7.87% |
Q4 2024 |
FY 2024 |
Share-based Payment Arrangement, Expense |
1.04M |
USD |
-0.19% |
Q2 2025 |
Q2 2025 |
Interest Expense |
23K |
USD |
+360% |
Q1 2024 |
Q1 2024 |